Current Diabetes Reports

, 15:567 | Cite as

Probiotics and Pregnancy

  • Luisa F. Gomez Arango
  • Helen L. Barrett
  • Leonie K. Callaway
  • Marloes Dekker NitertEmail author
Diabetes and Pregnancy (CJ Homko, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Diabetes and Pregnancy


Complications of pregnancy are associated with adverse outcomes for mother and baby in the short and long term. The gut microbiome has been identified as a key factor for maintaining health outside of pregnancy and could contribute to pregnancy complications. In addition, the vaginal and the recently revealed placental microbiome are altered in pregnancy and may play a role in pregnancy complications. Probiotic supplementation could help to regulate the unbalanced microflora composition observed in obesity and diabetes. Here, the impact of probiotic supplementation during pregnancy and infancy is reviewed. There are indications for a protective role in preeclampsia, gestational diabetes mellitus, vaginal infections, maternal and infant weight gain and allergic diseases. Large, well-designed randomised controlled clinical trials along with metagenomic analysis are needed to establish the role of probiotics in adverse pregnancy and infancy outcomes.


Probiotics Pregnancy Maternal microbiome Pregnancy complications Infant outcomes 


Compliance with Ethics Guidelines

Conflict of Interest

Luisa F. Gomez Arango declares that she has no conflict of interest.

Helen L. Barrett has received research support through a grant from Pfizer Australia.

Leonie K. Callaway and Marloes Dekker Nitert have received non-financial support from Christian Hansen A/S, which supplies probiotics and placebo capsules for the RCT run by these authors.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.••
    Aagaard K, Riehle K, Ma J, Segata N, Mistretta T-A, Coarfa C, et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE. 2012;7(6):e36466. doi: 10.1371/journal.pone.0036466. This study shows a complete comparative metagenomic characterization of the vaginal microbiota during pregnancy and non-pregnancy. PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.••
    Koren O, Goodrich Julia K, Cullender Tyler C, Spor A, Laitinen K, Kling Bäckhed H, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80. doi: 10.1016/j.cell.2012.07.008. The first approach showing the changes of the gut microbiota during pregnancy. PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Laker RC, Wlodek ME, Connelly JJ, Yan Z. Epigenetic origins of metabolic disease: the impact of the maternal condition to the offspring epigenome and later health consequences. Food Sci Hum Wellness. 2013;2(1):1–11. doi: 10.1016/j.fshw.2013.03.002.CrossRefGoogle Scholar
  4. 4.••
    Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014;6(237):237ra65. doi: 10.1126/scitranslmed.3008599. The first study to suggest that the placenta is not sterile, that it contains its own microbiome. PubMedCrossRefGoogle Scholar
  5. 5.
    Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010;33(10):2277–84. doi: 10.2337/dc10-0556.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Thum C, Cookson AL, Otter DE, McNabb WC, Hodgkinson AJ, Dyer J, et al. Can nutritional modulation of maternal intestinal microbiota influence the development of the infant gastrointestinal tract? J Nutr. 2012;142(11):1921–8. doi: 10.3945/jn.112.166231.PubMedCrossRefGoogle Scholar
  7. 7.
    Thomas DW, Greer FR. Probiotics and prebiotics in pediatrics. Pediatrics. 2010;126(6):1217–31. doi: 10.1542/peds.2010-2548.PubMedCrossRefGoogle Scholar
  8. 8.
    Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011;6(3):209–40. doi: 10.1007/s12263-011-0229-7.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. 2008;111:1–66. doi: 10.1007/10_2008_097.PubMedGoogle Scholar
  10. 10.
    Taibi A, Comelli EM. Practical approaches to probiotics use. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. 2014:1-7. doi: 10.1139/apnm-2013-0490.
  11. 11.
    Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. The Cochrane database of systematic reviews. 2011(3):Cd005496. doi: 10.1002/14651858.CD005496.pub3.
  12. 12.
    Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract. 2011;2011:161358. doi: 10.1155/2011/161358.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Gilbert Jack A, Krajmalnik-Brown R, Porazinska Dorota L, Weiss Sophie J, Knight R. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell. 2013;155(7):1446–8. doi: 10.1016/j.cell.2013.11.035.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59–65. doi: 10.1038/nature08821.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Lee WJ, Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat Chem Biol. 2014;10(6):416–24. doi: 10.1038/nchembio.1535.PubMedCrossRefGoogle Scholar
  16. 16.
    Harley IT, Karp CL. Obesity and the gut microbiome: striving for causality. Mol Metabolism. 2012;1(1–2):21–31. doi: 10.1016/j.molmet.2012.07.002.CrossRefGoogle Scholar
  17. 17.
    Mukhopadhya I, Hansen R, El-Omar EM, Hold GL. IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol. 2012;9(4):219–30. doi: 10.1038/nrgastro.2012.14.PubMedCrossRefGoogle Scholar
  18. 18.
    Avershina E, Storro O, Oien T, Johnsen R, Pope P, Rudi K. Major faecal microbiota shifts in composition and diversity with age in a geographically restricted cohort of mothers and their children. FEMS Microbiol Ecol. 2014;87(1):280–90. doi: 10.1111/1574-6941.12223.PubMedCrossRefGoogle Scholar
  19. 19.
    Jost T, Lacroix C, Braegger C, Chassard C. Stability of the maternal gut microbiota during late pregnancy and early lactation. Curr Microbiol. 2014;68(4):419–27. doi: 10.1007/s00284-013-0491-6.PubMedCrossRefGoogle Scholar
  20. 20.
    Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG Int J Obstet Gynaecol. 2011;118(5):533–49. doi: 10.1111/j.1471-0528.2010.02840.x.CrossRefGoogle Scholar
  21. 21.
    Romero R, Hassan SS, Gajer P, Tarca AL, Fadrosh DW, Nikita L, et al. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome. 2014;2(1):4. doi: 10.1186/2049-2618-2-4.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Consortium HMP. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486(7402):207–14. doi: 10.1038/nature11234.CrossRefGoogle Scholar
  23. 23.
    Karnik S, Kanekar A. Childhood obesity: a global public health crisis. Int J Prev Med. 2012;3(1):1–7.PubMedCentralPubMedGoogle Scholar
  24. 24.
    Rosenberg TJ, Garbers S, Lipkind H, Chiasson MA. Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am J Public Health. 2005;95(9):1545–51. doi: 10.2105/ajph.2005.065680.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Association AD. Gestational diabetes mellitus. Diabetes Care. 2004;27 Suppl 1:S88–90.Google Scholar
  26. 26.
    Van Lieshout RJ, Voruganti LP. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms. J Psychiatry Neurosci JPN. 2008;33(5):395–404.Google Scholar
  27. 27.
    Towpik I, Wender-Ozegowska E. Is diabetes mellitus worth treating? Ginekol Pol. 2014;85(3):220–5.PubMedGoogle Scholar
  28. 28.
    Chu SY, Callaghan WM, Kim SY, Schmid CH, Lau J, England LJ, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30(8):2070–6. doi: 10.2337/dc06-2559a.PubMedCrossRefGoogle Scholar
  29. 29.
    Halperin IJ, Feig DS. The role of lifestyle interventions in the prevention of gestational diabetes. Curr Diabetes Reports. 2014;14(1):452. doi: 10.1007/s11892-013-0452-2.CrossRefGoogle Scholar
  30. 30.
    Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 2008;88(4):894–9.PubMedGoogle Scholar
  31. 31.
    Collado MC, Isolauri E, Laitinen K, Salminen S. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92(5):1023–30. doi: 10.3945/ajcn.2010.29877.PubMedCrossRefGoogle Scholar
  32. 32.
    Santacruz A, Collado MC, Garcia-Valdes L, Segura MT, Martin-Lagos JA, Anjos T, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010;104(1):83–92. doi: 10.1017/s0007114510000176.PubMedCrossRefGoogle Scholar
  33. 33.
    Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014. doi: 10.1136/gutjnl-2014-306928.Google Scholar
  34. 34.
    Ma J, Prince AL, Bader D, Hu M, Ganu R, Baquero K, et al. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun. 2014;5:3889. doi: 10.1038/ncomms4889.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–3. doi: 10.1038/4441022a.PubMedCrossRefGoogle Scholar
  36. 36.
    Conterno L, Fava F, Viola R, Tuohy KM. Obesity and the gut microbiota: does up-regulating colonic fermentation protect against obesity and metabolic disease? Genes Nutr. 2011;6(3):241–60. doi: 10.1007/s12263-011-0230-1.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5(2):e9085. doi: 10.1371/journal.pone.0009085.PubMedCentralPubMedCrossRefGoogle Scholar
  38. 38.
    Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi: 10.1038/nature11450.PubMedCrossRefGoogle Scholar
  39. 39.
    Hu J, Nomura Y, Bashir A, Fernandez-Hernandez H, Itzkowitz S, Pei Z, et al. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One. 2013;8(11):e78257. doi: 10.1371/journal.pone.0078257.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Ilmonen J, Isolauri E, Poussa T, Laitinen K. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clin Nutr (Edinb Scotl). 2011;30(2):156–64. doi: 10.1016/j.clnu.2010.09.009.CrossRefGoogle Scholar
  41. 41.•
    Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counselling on pregnancy outcome and prenatal and postnatal growth: a double-blind, placebo-controlled study. Br J Nutr. 2010;103(12):1792–9. doi: 10.1017/s0007114509993898. This is an important trial providing evidence of probiotics in the prevention of GDM. PubMedCrossRefGoogle Scholar
  42. 42.
    Nitert MD, Barrett HL, Foxcroft K, Tremellen A, Wilkinson S, Lingwood B, et al. SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women. BMC Pregnancy Childbirth. 2013;13:50. doi: 10.1186/1471-2393-13-50.PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. The Cochrane database of systematic reviews. 2007(1):Cd005941. doi: 10.1002/14651858.CD005941.pub2.
  44. 44.
    Rushing J, Neu J. Probiotics for pregnant women and preterm neonates. Am J Clin Nutr. 2011;93(1):3–4. doi: 10.3945/ajcn.110.006346.PubMedCrossRefGoogle Scholar
  45. 45.
    Othman M. ProB Trial: probiotics and the prevention of preterm labour; a randomised controlled trial protocol. WebmedCentral Obstetrics and Gynaecology 2012;3(6).Google Scholar
  46. 46.
    Vitali B, Cruciani F, Baldassarre ME, Capursi T, Spisni E, Valerii MC, et al. Dietary supplementation with probiotics during late pregnancy: outcome on vaginal microbiota and cytokine secretion. BMC Microbiol. 2012;12:236. doi: 10.1186/1471-2180-12-236.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Polatti F. Bacterial vaginosis, Atopobium vaginae and nifuratel. Curr Clin Pharmacol. 2012;7(1):36–40.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Yang S, Li W, Challis JR, Reid G, Kim SO, Bocking AD. Probiotic Lactobacillus rhamnosus GR-1 supernatant prevents lipopolysaccharide-induced preterm birth and reduces inflammation in pregnant CD-1 mice. Am J Obstet Gynecol. 2014. doi: 10.1016/j.ajog.2014.01.029.Google Scholar
  49. 49.
    Thompson ML, Ananth CV, Jaddoe VW, Miller RS, Williams MA. The association of maternal adult weight trajectory with preeclampsia and gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2014. doi: 10.1111/ppe.12128.PubMedGoogle Scholar
  50. 50.
    Hauth JC, Clifton RG, Roberts JM, Myatt L, Spong CY, Leveno KJ, et al. Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol. 2011;204(4):327.e1–6. doi: 10.1016/j.ajog.2011.02.024.CrossRefGoogle Scholar
  51. 51.•
    Brantsaeter AL, Myhre R, Haugen M, Myking S, Sengpiel V, Magnus P, et al. Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study. Am J Epidemiol. 2011;174(7):807–15. doi: 10.1093/aje/kwr168. This cohort study shows that consumption of probiotic diary products is associated with reduced risk of preeclampsia.PubMedCentralPubMedCrossRefGoogle Scholar
  52. 52.
    Lye H-S, Rahmat-Ali GR, Liong M-T. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20(3):169–75. doi: 10.1016/j.idairyj.2009.10.003.CrossRefGoogle Scholar
  53. 53.
    Ooi L-G, Liong M-T. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci. 2010;11(6):2499–522.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Asemi Z, Samimi M, Tabasi Z, Talebian P, Azarbad Z, Hydarzadeh Z, et al. Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial. J matern-fetal Neonatal Med Off J Eur Assoc Perinatal Med Fed Asia Ocean Perinatal Soc Int Soc Perinatal Obstet. 2012;25(9):1552–6. doi: 10.3109/14767058.2011.640372.CrossRefGoogle Scholar
  55. 55.
    Hoppu U, Isolauri E, Koskinen P, Laitinen K. Maternal dietary counseling reduces total and LDL cholesterol postpartum. Nutr (Burbank Los Angel County Calif). 2014;30(2):159–64. doi: 10.1016/j.nut.2013.07.009.CrossRefGoogle Scholar
  56. 56.•
    Luoto R, Kalliomaki M, Laitinen K, Isolauri E. The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. Int J Obes (2005). 2010;34(10):1531–7. doi: 10.1038/ijo.2010.50. This follow-up study shows that intake of probiotics during pregnancy and infancy can restrain excessive weight gain during the first years of life. CrossRefGoogle Scholar
  57. 57.
    Osborn DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. The Cochrane database of systematic reviews. 2007(4):Cd006475. doi: 10.1002/14651858.CD006475.pub2.
  58. 58.
    Forno E, Onderdonk AB, McCracken J, Litonjua AA, Laskey D, Delaney ML, et al. Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy CMA. 2008;6:11. doi: 10.1186/1476-7961-6-11.CrossRefGoogle Scholar
  59. 59.
    Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, et al. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2012;42(1):112–22. doi: 10.1111/j.1365-2222.2011.03885.x.CrossRefGoogle Scholar
  60. 60.
    Bertelsen RJ, Brantsaeter AL, Magnus MC, Haugen M, Myhre R, Jacobsson B, et al. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J Allergy Clin Immunol. 2014;133(1):165–71.e1-8. doi: 10.1016/j.jaci.2013.07.032.PubMedCentralPubMedCrossRefGoogle Scholar
  61. 61.
    Ly NP, Litonjua A, Gold DR, Celedón JC. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127(5):1087–94. doi: 10.1016/j.jaci.2011.02.015.PubMedCentralPubMedCrossRefGoogle Scholar
  62. 62.
    Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood—a meta-analysis. Br J Nutr. 2012;107(1):1–6. doi: 10.1017/s0007114511003400.PubMedCrossRefGoogle Scholar
  63. 63.
    Wickens K, Stanley TV, Mitchell EA, Barthow C, Fitzharris P, Purdie G, et al. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43(9):1048–57. doi: 10.1111/cea.12154.CrossRefGoogle Scholar
  64. 64.
    Loo EX, Llanora GV, Lu Q, Aw MM, Lee BW, Shek LP. Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol. 2014;163(1):25–8. doi: 10.1159/000356338.PubMedCrossRefGoogle Scholar
  65. 65.
    Forsberg A, Abrahamsson TR, Bjorksten B, Jenmalm MC. Pre- and post-natal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2013;43(4):434–42. doi: 10.1111/cea.12082.CrossRefGoogle Scholar
  66. 66.
    Prescott SL, Wickens K, Westcott L, Jung W, Currie H, Black PN, et al. Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-gamma and breast milk transforming growth factor-beta and immunoglobin A detection. Clinical Exp Allergy J Br Soc Allergy Clin Immunol. 2008;38(10):1606–14. doi: 10.1111/j.1365-2222.2008.03061.x.CrossRefGoogle Scholar
  67. 67.
    Gloudemans AK, Lambrecht BN, Smits HH. Potential of immunoglobulin A to prevent allergic asthma. Clin Dev Immunol. 2013;2013:542091. doi: 10.1155/2013/542091.PubMedCentralPubMedCrossRefGoogle Scholar
  68. 68.
    AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. The Cochrane database of systematic reviews. 2014;4:Cd005496. doi: 10.1002/14651858.CD005496.pub4.
  69. 69.
    Hartel C, Pagel J, Rupp J, Bendiks M, Guthmann F, Rieger-Fackeldey E, et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very Low birth weight infants. J Pediatr. 2014. doi: 10.1016/j.jpeds.2014.04.029.PubMedGoogle Scholar
  70. 70.
    Braga TD, da Silva GA, de Lira PI, de Carvalho LM. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81–6. doi: 10.3945/ajcn.2010.29799.PubMedCrossRefGoogle Scholar
  71. 71.
    Awad H, Mokhtar H, Imam SS, Gad GI, Hafez H, Aboushady N. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci PJBS. 2010;13(6):253–62.CrossRefGoogle Scholar
  72. 72.
    Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montano-Rodriguez R, et al. Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5–9. doi: 10.1136/archdischild-2011-300435.PubMedCrossRefGoogle Scholar
  73. 73.
    Boyle RJR-B, Roy M. Probiotic use in clinical practice: what are the risks? The American journal of clinical nutrition. 2006;83(6).Google Scholar
  74. 74.
    Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Phys Medecin de famille canadien. 2011;57(3):299–301.Google Scholar
  75. 75.
    Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–80. doi: 10.1038/nature09944.PubMedCentralPubMedCrossRefGoogle Scholar
  76. 76.
    Mendz GL LS, Kaakoush NO, Quinlivan JA. Vaginal microbiome of pregnant women of three ethnic backgrounds in health and disease. In proceeding of: Perinatal Society of Australia and New Zealand Annual Scientific Meeting, At Perth, Western Australia. 2014.Google Scholar
  77. 77.
    Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–70. doi: 10.1038/nrg3182.PubMedCentralPubMedGoogle Scholar
  78. 78.
    Guelinckx I, Devlieger R, Beckers K, Vansant G. Maternal obesity: pregnancy complications, gestational weight gain and nutrition. Obes Rev Off J Int Assoc Study Obes. 2008;9(2):140–50. doi: 10.1111/j.1467-789X.2007.00464.x.CrossRefGoogle Scholar
  79. 79.
    Organization WH. WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia. WHO Library Cataloguing-in-Publication Data. 2011.Google Scholar
  80. 80.
    Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi: 10.1016/s0140-6736(08)60074-4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Luisa F. Gomez Arango
    • 1
    • 2
  • Helen L. Barrett
    • 1
    • 2
  • Leonie K. Callaway
    • 1
  • Marloes Dekker Nitert
    • 1
    • 2
    Email author
  1. 1.School of MedicineThe University of QueenslandHerstonAustralia
  2. 2.UQ Centre for Clinical ResearchThe University of QueenslandHerstonAustralia

Personalised recommendations